Source:
Summary
Australian tech entrepreneur Paul Conyngham used AI to create a custom mRNA cancer vaccine for his dog Rosie after traditional treatments failed. With the help of scientists at the University of New South Wales, Conyngham developed a bespoke vaccine that has shrunk most of Rosie’s tumors. The treatment was made possible with the help of OpenAI’s ChatGPT and Google’s AlphaFold.
The Numbers Tell One Story
According to the report, Rosie’s tumors have shrunk dramatically after receiving the custom mRNA cancer vaccine. The vaccine was developed in less than two months, and Rosie received her first injection in December, followed by a booster in February.
Our Reading
The announcement sounds familiar. A tech entrepreneur uses AI to solve a personal problem, and the results are impressive. But what happens when this technology is applied to humans? The strategy enters a familiar phase, where the lines between tech and medicine become increasingly blurred. The numbers tell one story, but the real story is about the potential of AI to democratize cancer treatment.
The original observation: “This is what I mean when I say the world is going to get very weird, very soon.”
Author:
Evan Null
